Institution
National Center for Immunization and Respiratory Diseases
USfacility
Recent research
- Health & Medicine
BACKGROUND: The introduction of rotavirus vaccines in the United States in 2006 and 2008 has had large impacts on reducing rotavirus- and diarrhea-associated healthcare utilization. We evaluated changes in diarrhea-associated mortality from 2005 to 2024 among children 1-59 months...
- Health & Medicine
Effectiveness of RSV Prevention Strategies in US Infants: 2024–2025
OBJECTIVE: In 2023, 2 products, a long-acting monoclonal antibody (nirsevimab) and maternal respiratory syncytial virus (RSV) vaccination, were recommended in the United States to prevent severe RSV disease among infants in their first RSV season. Low uptake during the 2023 to 20...